Rasna Therapeutics (RASP) Price & Analysis

3 Followers

RASP Stock Chart & Stats

$0.01

>-$0.01(-95.00%)

At close: Dec 26 4:00 PM EST

$0.01

>-$0.01(-95.00%)

Day’s Range― - ―

52-Week Range$0.01 - $0.01

Previous CloseN/A

Volume20.00K

Average Volume (3M)0.00

Market Cap

$385.91K

Enterprise Value$521.89K

Total Cash (Recent Filing)$1.39K

Total Debt (Recent Filing)$303.96K

Price to Earnings (P/E)―

Beta-0.45

Next EarningsN/A

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)>-0.01

Shares Outstanding771,811,340

10 Day Avg. Volume0

30 Day Avg. Volume0

Financial Highlights & Ratios

PEG Ratio0.11

Price to Book (P/B)-5.91

Price to Sales (P/S)0.00

P/FCF Ratio-1.36K

Enterprise Value/Market Cap1.35

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/Ebitda-1.71

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)N/A

Revenue Forecast (FY)N/A

RASP FAQ

What was Rasna Therapeutics Inc’s price range in the past 12 months?

Rasna Therapeutics Inc lowest stock price was $0.01 and its highest was $0.01 in the past 12 months.

What is Rasna Therapeutics Inc’s market cap?

Rasna Therapeutics Inc’s market cap is $385.91K.

When is Rasna Therapeutics Inc’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Rasna Therapeutics Inc’s earnings last quarter?

Rasna Therapeutics Inc released its earnings results on May 10, 2018. The company reported -$0.02 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.02.

Is Rasna Therapeutics Inc overvalued?

According to Wall Street analysts Rasna Therapeutics Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Rasna Therapeutics Inc pay dividends?

Rasna Therapeutics Inc does not currently pay dividends.

What is Rasna Therapeutics Inc’s EPS estimate?

Rasna Therapeutics Inc’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Rasna Therapeutics Inc have?

Rasna Therapeutics Inc has 771,811,340 shares outstanding.

What happened to Rasna Therapeutics Inc’s price movement after its last earnings report?

Rasna Therapeutics Inc reported an EPS of -$0.02 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same N/A.

Which hedge fund is a major shareholder of Rasna Therapeutics Inc?

Currently, no hedge funds are holding shares in RASP

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Rasna Therapeutics Inc

Actavia Life Sciences, Inc. operates as a biotechnology enterprise specializing in the development of therapeutic solutions aimed at treating various forms of leukemia and lymphoma. Additionally, the company is engaged in formulating small molecule drug candidates, with a particular emphasis on addressing acute myeloid leukemia. Established in 2013, its corporate headquarters are situated in New York, NY.